本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

64.63
+1.923.06%
盤後64.630.00000.00%17:52 EDT
成交量:108.79萬
成交額:6,989.53萬
市值:41.10億
市盈率:-14.90
高:65.53
開:61.07
低:60.00
收:62.71
資料載入中...
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]